Generate a tailored SOP for Dr. Asha Patel. Improve your application with a focused, well-structured draft.
The Patel group converges expertise in pharmaceutical chemistry, biomaterials, and regenerative medicine to develop advanced therapies that restore tissue homeostasis after injury, cancer, and infection. Current research focuses on the development of biomaterials for gene transfer to target cells, as well as engineering mRNA to control protein pharmacokinetics and the application of RNA technologies in diseases with limited treatment options. Asha joined the department in 2018 after completing 4 years of postdoctoral training as an EPSRC Early Career Fellow in the laboratories of Professors Daniel Anderson and Robert Langer at the Massachusetts Institute of Technology, USA, where she pioneered biodegradable polymer nanoformulations for inhaled mRNA delivery to the lung. Asha graduated with a first-class honours degree in Pharmacy from King's College London in 2006 and is a member of the Royal Pharmaceutical Society. In 2014, she was awarded a PhD from the University of Nottingham as part of the Doctoral Training Centre in Regenerative Medicine, where she investigated the impact of biomaterial chemical diversity on human pluripotent stem cell and cardiomyocyte behaviour, under the guidance of Professors Chris Denning, Morgan Alexander, and Martyn Davies. Asha is interested in joining research groups, and has made competitive applications for funding including the President's PhD Scholarship and the Lee Family Scholarships, as well as Imperial College Postdoctoral Research Fellowships for the Faculty of Medicine.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.